Back to search

National and Kapodistrian University of Athens

Μελέτη του μεταβολισμού και της δράσης του παράγοντα ενεργοποίησης των αιμοπεταλίων σε ανθρώπινο νεφρικό ιστό και νεφρικά κύτταρα

Abstract

dc:description

Platelet activating factor (PAF) is a potent inflammatory mediator that is produced by a variety of cells. It is biosynthesized either by remodeling pathway from membrane phospholipids either by de novo pathway of glyceryl-ether lipids. Remodeling pathway is activated in inflammatory conditions while de novo pathway produces PAF under physiological conditions. The study of PAF metabolism enzymes is of great important since they are responsible for pathological and physiological PAF levels. Several studies indicated PAF participation in the pathogenesis of many renal diseases. Glomerulosclerosis (GS) is the common pathological feature in most renal diseases and is highly correlated with the progression of renal failure. Although numerous attempts have been made to elucidate the mechanisms underlying glomerulosclerosis, the precise pathogenesis remains undetermined. GS and atherosclerosis are thought to share a common pathogenesis and the term ‘Glomerular atherosclerosis’ has been proposed. Unregulated intracellular lipid accumulation is thought to be critical step in the development of the two diseases and may happen through scavenger receptors or dysregulation of LDL receptors. The aim of the study is 1. To exam the enzyme acetyl-CoA:lyso-PAF acetyltransferase (lyso-PAF AT) of remodeling pathway in human kidney and mesangial cells. In order to do that yhe fraction of total membranes, from human renal tissue and from human mesangial cell line (HMC), was obtained and enzymatic activity was determined by trichloroacetic acid precipitation method. The optimal reaction conditions were estimated for lyso-PAF AT from HMC, more specific optimal temperature was 37οC, optimal pH 7.2-7.4 and concentrations of lyso-PAF and acetyl-CoA 20 μΜ and 200 μΜ respectively. The values of Κm (μΜ) and Vmax (nmol/min/mg) were determined with respect to lyso-PAF 45.2 ± 9.37, 9.37 ± 3.1 and with respect to acetyl-CoA 71.2 ± 15.1, 2.83 ± 0.252, respectively. High concentrations of Mg2+ and Ca2+ partly inhibit enzyme action. EDTA also inhibits the enzyme action and this inhibition is reversible with exogenous addition of Ca2+. BSA, Naf and pefabloc does not influence the activity while inhibition was observed with addition of DTT and mercaptoethanol. Various detergents were tested for the 189 solubilization of enzyme from human kidney and mesangial cells. Only glycerol successfully solubilaze the enzyme without inactivation. Solubilized fractions were successfully purified on HPLC with anion exchange column. Solubilazed fraction from human kidney and active fractions from HPLC from HMC were subjects in native-PAGE. Two active were arisen from both in region of MW 25-30 kDa and 65-80 kDa. 2. To investigate the mechanism of PAF implication in glomerulosclerosis and especially in mesangial cells function. In order to do that the effect of PAF in intracellular lipid accumulation and in activation of the pro-inflammatory transcription factor NF-kB was investigated. A single class of PAF receptor was identified with Kd = 17.5 nM and Βmax = 4.01 pmol/mg of cell protein. Morphological experiments reveal that LDL is able foam cell formation in the presence to cause that PAF (10-6 M). This formation is inhibited by heparin and by BN520121 ahile polyinosic acid did not affect it. In addition PAF (10-6 M) increase levels of LDLr mRNA within 2h (peaked in 12h) even in the presence of excess LDL suggesting that PAF overrides the sterol mediated regulation of LDLr. Lower concentration of PAF (10-9 M) increased the expression of SCr within 2h (peaked at 6h). The effect of various signal transduction inhibitors in PAF action was studied. Moreover PAF (10-9 & 10-6 M) caused NF-kB activation in mesangial cells within 0.5 h and this activation persisted for 24 h. In addition PAF increases mRNA of its receptor possible through activation of NF-kB since promotor 1 of PAFR was detected. This data suggests that PAF may contribute to the progression of renal injury by causing lipid accumulation and activation of pro-inflammatory transcription factor pathways in mesangial cells.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2004

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Fragopoulou, Elizabeth
  • Φραγκοπούλου, Ελισσάβετ

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/14139

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Fragopoulou, Elizabeth; Φραγκοπούλου, Ελισσάβετ. Μελέτη του μεταβολισμού και της δράσης του παράγοντα ενεργοποίησης των αιμοπεταλίων σε ανθρώπινο νεφρικό ιστό και νεφρικά κύτταρα. National and Kapodistrian University of Athens, 2004. http://hdl.handle.net/10442/hedi/14139